Free Trial

Healthcare Realty Trust Incorporated (NYSE:HR) Shares Sold by Impax Asset Management Group plc

Healthcare Realty Trust logo with Finance background

Impax Asset Management Group plc cut its holdings in shares of Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) by 43.4% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 400,000 shares of the real estate investment trust's stock after selling 306,352 shares during the period. Impax Asset Management Group plc owned 0.11% of Healthcare Realty Trust worth $7,260,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Centersquare Investment Management LLC bought a new position in shares of Healthcare Realty Trust during the first quarter valued at approximately $1,246,000. SG Americas Securities LLC boosted its stake in Healthcare Realty Trust by 394.9% in the first quarter. SG Americas Securities LLC now owns 388,015 shares of the real estate investment trust's stock valued at $5,490,000 after acquiring an additional 309,609 shares in the last quarter. Vanguard Group Inc. boosted its stake in Healthcare Realty Trust by 1.4% in the first quarter. Vanguard Group Inc. now owns 54,246,277 shares of the real estate investment trust's stock valued at $767,585,000 after acquiring an additional 723,197 shares in the last quarter. GSA Capital Partners LLP acquired a new stake in Healthcare Realty Trust in the first quarter valued at approximately $719,000. Finally, Tidal Investments LLC acquired a new stake in Healthcare Realty Trust in the first quarter valued at approximately $1,360,000.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on HR shares. Scotiabank lifted their price objective on shares of Healthcare Realty Trust from $17.00 to $18.00 and gave the stock a "sector perform" rating in a research note on Wednesday, August 7th. Wells Fargo & Company reiterated an "underweight" rating and set a $17.00 price objective (up from $16.00) on shares of Healthcare Realty Trust in a research note on Tuesday, October 1st. Finally, Wedbush lifted their price objective on shares of Healthcare Realty Trust from $15.00 to $18.00 and gave the stock a "neutral" rating in a research note on Monday, August 5th. One analyst has rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $17.17.

Read Our Latest Report on HR

Insider Buying and Selling

In other news, Director John Knox Singleton bought 6,500 shares of the firm's stock in a transaction on Thursday, September 5th. The shares were bought at an average cost of $18.24 per share, for a total transaction of $118,560.00. Following the acquisition, the director now directly owns 57,082 shares of the company's stock, valued at $1,041,175.68. This trade represents a 0.00 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. In other Healthcare Realty Trust news, Director Thomas N. Bohjalian bought 9,000 shares of Healthcare Realty Trust stock in a transaction on Monday, August 12th. The shares were bought at an average cost of $17.39 per share, for a total transaction of $156,510.00. Following the acquisition, the director now directly owns 22,252 shares in the company, valued at $386,962.28. This represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director John Knox Singleton bought 6,500 shares of Healthcare Realty Trust stock in a transaction on Thursday, September 5th. The shares were acquired at an average price of $18.24 per share, for a total transaction of $118,560.00. Following the completion of the acquisition, the director now owns 57,082 shares in the company, valued at $1,041,175.68. This represents a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 15,728 shares of company stock worth $279,069. 0.56% of the stock is owned by insiders.

Healthcare Realty Trust Stock Performance

Shares of HR stock traded down $0.46 on Wednesday, reaching $17.11. 3,730,004 shares of the company were exchanged, compared to its average volume of 3,473,600. The company has a market cap of $6.21 billion, a price-to-earnings ratio of -11.13 and a beta of 0.91. The business has a 50-day moving average price of $17.86 and a 200 day moving average price of $17.00. Healthcare Realty Trust Incorporated has a 1 year low of $12.77 and a 1 year high of $18.90.

Healthcare Realty Trust Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, November 27th. Investors of record on Tuesday, November 12th will be given a dividend of $0.31 per share. The ex-dividend date of this dividend is Tuesday, November 12th. This represents a $1.24 dividend on an annualized basis and a yield of 7.25%. Healthcare Realty Trust's payout ratio is presently -78.48%.

Healthcare Realty Trust Company Profile

(Free Report)

Healthcare Realty NYSE: HR is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty's portfolio includes more than 700 properties totaling over 40 million square feet concentrated in 15 growth markets.

See Also

Institutional Ownership by Quarter for Healthcare Realty Trust (NYSE:HR)

Should you invest $1,000 in Healthcare Realty Trust right now?

Before you consider Healthcare Realty Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthcare Realty Trust wasn't on the list.

While Healthcare Realty Trust currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines